Gene · 2492
Papers3,947
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,947
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic analyses and molecular associations of FSHR and GH genes for semen traits in Egyptian buffalo. | BMC Vet Res | 2025 | 40616069 | PubTator, text mining | PubMed |
| Role of follicle-stimulating hormone receptor polymorphism in predicting ovarian response to letrozole in women with polycystic ovary syndrome during ovulation induction. | Front Endocrinol (Lausanne) | 2025 | 40612432 | PubTator, text mining | PubMed |
| Effects of Testosterone on Cumulus Cells Gene Expression in Patients with Diminished Ovarian Reserve. | Reprod Sci | 2025 | 40588714 | PubTator, text mining | PubMed |
| Ferroptosis and Sterol Biosynthesis Dysregulation in Granulosa Cells of Patients with Diminished Ovarian Reserve. | Antioxidants (Basel) | 2025 | 40563381 | PubTator, text mining | PubMed |
| Prevalence and genetic etiology of poly-cystic ovarian syndrome (PCOS) in Mauritania. | Front Reprod Health | 2025 | 40551954 | PubTator, text mining | PubMed |
| Genetics of ovulatory dysfunction and infertility: a scoping review and gene ontology analysis. | Front Endocrinol (Lausanne) | 2025 | 40535332 | PubTator, text mining | PubMed |
| Targeting programmed cell death with natural products: a potential therapeutic strategy for diminished ovarian reserve and fertility preservation. | Front Pharmacol | 2025 | 40510420 | PubTator, text mining | PubMed |
| Targeted destruction of follicle stimulating hormone receptor-positive cancer cells in vitro and in vivo by a lytic peptide Phor21-FSHβ conjugate. | Mol Med | 2025 | 40490708 | PubTator, text mining | PubMed |
| Metformin-Driven Activation of Polymorphic Follicle-Stimulating Hormone Receptors for Polycystic Ovary Syndrome Treatment: A Computational Study. | Med Sci Monit | 2025 | 40485087 | PubTator, text mining | PubMed |
| Propofol-mediated inhibition of ovarian function by mitophagy over-activation via TGF-β1/SMAD2/3 signaling pathway. | Cell Signal | 2025 | 40480431 | PubTator, text mining | PubMed |
| FSH receptor N680S genotype-guided gonadotropin choice increases cumulative pregnancy and live birth rates after in vitro fertilization. | Front Endocrinol (Lausanne) | 2025 | 40433406 | PubTator, text mining | PubMed |
| Changes in Ovarian Activity and Expressions of Follicle Development Regulation Factors During the Laying-Incubation Cycle in Magang Geese. | Animals (Basel) | 2025 | 40427268 | PubTator, text mining | PubMed |
| PCOS and Inositols - Advances and Lessons We are Learning. A Narrative Review. | Drug Des Devel Ther | 2025 | 40420946 | PubTator, text mining | PubMed |
| [Molecular genetics in pediatric endocrinology: 35 years of research]. | Probl Endokrinol (Mosk) | 2025 | 40411325 | PubTator, text mining | PubMed |
| Targeting FSHR is a highly promising strategy for improving cognitive impairment in postmenopausal women. | Mol Psychiatry | 2025 | 40399468 | PubTator, text mining | PubMed |
| The expression of follicle-stimulating hormone receptor (FSHR) and nerve growth factor (NGF) in endometriomas. | Arch Med Sci | 2025 | 40395904 | PubTator, text mining | PubMed |
| Effectiveness of recombinant follicle-stimulating hormone treatment in patients with oligo-asthenospermia at different levels of DNA fragmentation index: A phase II clinical trial. | Curr Urol | 2025 | 40376468 | PubTator, text mining | PubMed |
| GzESTY as an optimized cell-based assay for initial steps in GPCR deorphanization. | Nat Commun | 2025 | 40374633 | PubTator, text mining | PubMed |
| Effect of resistance training on body composition and physical function in older females with sarcopenic obesity-a systematic review and meta-analysis of randomized controlled trials. | Front Aging Neurosci | 2025 | 40370749 | PubTator, text mining | PubMed |
| Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements. | J Transl Med | 2025 | 40369674 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2492/papers?page=8